Recent News

• 03.20.2025 - Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
• 01.10.2025 - Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
• 11.25.2024 - Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
• 11.19.2024 - November 19, 2024 - November 21, 2024 : Jefferies London Healthcare Conference 2024
• 11.15.2024 - November 15, 2024 - October 21, 2024 : The American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® 2024
• 11.15.2024 - November 15, 2024 - November 19, 2024 : The American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® 2024
• 11.11.2024 - November 11, 2024 - November 13, 2024 : Guggenheim Securities Healthcare Innovation Conference

Recent Filings

• 02.11.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.10.2025 - 8-K Current report
• 01.10.2025 - EX-99.1 EX-99.1
• 12.31.2024 - 3/A Initial statement of beneficial ownership of securities
• 12.20.2024 - 3 Initial statement of beneficial ownership of securities
• 11.25.2024 - 8-K Current report